title: Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up.
authors.affiliation: 'Diagnosis and Therapy of HIV Infection' Unit, G.B. Rossi University Hospital, Verona, Italy.|Infectious Diseases Unit, G.B. Rossi University Hospital, Verona, Italy.
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Lanzafame
authors.affiliation: Infectious Diseases Unit, G.B. Rossi University Hospital, Verona, Italy.
authors.forename: Stefano
authors.initials: S
authors.lastname: Nicolè
authors.affiliation: Microbiology Unit, G.B. Rossi University Hospital, Verona, Italy.
authors.forename: Davide
authors.initials: D
authors.lastname: Gibellini
authors.affiliation: Infectious Diseases Unit, G.B. Rossi University Hospital, Verona, Italy.
authors.forename: Emanuela
authors.initials: E
authors.lastname: Lattuada
authors.affiliation: Infectious Diseases Unit, G.B. Rossi University Hospital, Verona, Italy.
authors.forename: Giulia
authors.initials: G
authors.lastname: Cucchetto
authors.affiliation: Infectious Diseases Unit, G.B. Rossi University Hospital, Verona, Italy.
authors.forename: Fabio
authors.initials: F
authors.lastname: Rigo
authors.affiliation: Microbiology Unit, G.B. Rossi University Hospital, Verona, Italy.
authors.forename: Erica
authors.initials: E
authors.lastname: Diani
authors.affiliation: Infectious Diseases Unit, G.B. Rossi University Hospital, Verona, Italy.
authors.forename: Ercole
authors.initials: E
authors.lastname: Concia
authors.affiliation: Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.|Nazarbayev University Medical Center, Astana, Kazakhstan.
authors.forename: Sandro
authors.initials: S
authors.lastname: Vento
mesh_terms: D000328:Adult; D000368:Aged; D018791:CD4 Lymphocyte Count; D002784:Cholesterol / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000235:genetics; D006575:Heterocyclic Compounds, 3-Ring / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D012367:RNA, Viral / Q000097:blood; D014280:Triglycerides / Q000097:blood; D019562:Viral Load / Q000187:drug effects; D000099226:Dolutegravir
chemical_list: D002784:Cholesterol; D019428:HIV Integrase Inhibitors; D006575:Heterocyclic Compounds, 3-Ring; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D012367:RNA, Viral; D014280:Triglycerides; D000099226:Dolutegravir